blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2382971

EP2382971 - ORALLY DISINTEGRATING TABLET HAVING INNER CORE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.01.2020
Database last updated on 25.09.2024
FormerGrant of patent is intended
Status updated on  31.03.2019
FormerExamination is in progress
Status updated on  10.05.2017
Most recent event   Tooltip10.01.2020Application deemed to be withdrawnpublished on 12.02.2020  [2020/07]
Applicant(s)For all designated states
Sumitomo Dainippon Pharma Co., Ltd.
6-8, Dosho-machi 2-chome
Chuo-ku
Osaka-shi
Osaka 541-8524 / JP
[2014/48]
Former [2011/44]For all designated states
Dainippon Sumitomo Pharma Co., Ltd.
6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi
Osaka 541-8524 / JP
Inventor(s)01 / MATONO, Mitsuhiro
c/o Dainippon Sumitomo Pharma Co. Ltd.
3-45 Kurakakiuchi 1-chome
Ibaraki-shi Osaka 567-0878 / JP
02 / KOBAYASHI, Hirohisa
c/o Dainippon Sumitomo Pharma Co. Ltd.
3-45 Kurakakiuchi 1-chome
Ibaraki-shi Osaka 567-0878 / JP
03 / IKEDA, Yuki
c/o Dainippon Sumitomo Pharma Co. Ltd.
3-45 Kurakakiuchi 1-chome
Ibaraki-shi Osaka 567-0878 / JP
04 / OCHIAI, Yasushi
c/o Dainippon Sumitomo Pharma Co. Ltd.
3-45 Kurakakiuchi 1-chome
Ibaraki-shi Osaka 567-0878 / JP
 [2011/44]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2011/44]Webster, Jeremy Mark, et al
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date10735924.229.01.2010
WO2010JP51294
Priority number, dateJP2009001867729.01.2009         Original published format: JP 2009018677
[2011/44]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010087462
Date:05.08.2010
Language:JA
[2010/31]
Type: A1 Application with search report 
No.:EP2382971
Date:02.11.2011
Language:EN
[2011/44]
Search report(s)International search report - published on:JP05.08.2010
(Supplementary) European search report - dispatched on:EP10.12.2013
ClassificationIPC:A61K9/30, A61K47/02, A61K47/20, A61K47/22, A61K47/46, A61K9/00, A61K9/28
[2014/02]
CPC:
A61K9/0056 (EP,CN,KR,US); A61K9/2813 (EP,CN,KR,US); A61K9/2826 (EP,CN,KR,US);
A61K9/286 (CN); A61K9/2893 (KR)
Former IPC [2011/44]A61K9/30, A61K47/02, A61K47/20, A61K47/22, A61K47/46
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR 
TitleGerman:IM MUND ZERFALLENDE TABLETTE MIT INNEREM KERN[2011/44]
English:ORALLY DISINTEGRATING TABLET HAVING INNER CORE[2011/44]
French:COMPRIMÉ À DÉSINTÉGRATION ORALE COMPORTANT UN NOYAU INTÉRIEUR[2011/44]
Entry into regional phase13.07.2011Translation filed 
28.07.2011National basic fee paid 
28.07.2011Search fee paid 
28.07.2011Designation fee(s) paid 
28.07.2011Examination fee paid 
Examination procedure28.07.2011Examination requested  [2011/44]
09.07.2014Amendment by applicant (claims and/or description)
04.02.2016Despatch of a communication from the examining division (Time limit: M04)
03.06.2016Reply to a communication from the examining division
03.05.2017Despatch of a communication from the examining division (Time limit: M06)
10.11.2017Reply to a communication from the examining division
04.09.2018Despatch of a communication from the examining division (Time limit: M04)
08.01.2019Reply to a communication from the examining division
01.04.2019Communication of intention to grant the patent
13.08.2019Application deemed to be withdrawn, date of legal effect  [2020/07]
30.09.2019Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2020/07]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.02.2016
Fees paidRenewal fee
20.01.2012Renewal fee patent year 03
21.01.2013Renewal fee patent year 04
24.01.2014Renewal fee patent year 05
26.01.2015Renewal fee patent year 06
25.01.2016Renewal fee patent year 07
23.01.2017Renewal fee patent year 08
25.01.2018Renewal fee patent year 09
16.01.2019Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2005202082  (HIBINO TSUNEYUKI [JP], et al) [A] 1-10* examples 1-9 *;
 [Y]WO2007065448  (LUNDBECK & CO AS H [DK], et al) [Y] 1-10 * page 16 - page 17; tables 2, 6 *;
 [Y]US2008269301  (YOKOE JUNICHI [JP], et al) [Y] 1-10 * examples 1-4 *;
 [E]EP2415466  (TORAY INDUSTRIES [JP]) [E] 1,3-5,10 * examples 6-26 *;
 [A]  - DESAI D S ET AL, "Photostabilization of uncoated tablets of sorivudine and nifedipine by incorporation of synthetic iron oxides", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 103, no. 1, doi:10.1016/0378-5173(94)90204-6, ISSN 0378-5173, (19940225), pages 69 - 76, (19940225), XP025577911 [A] 1-10 * page 70 *

DOI:   http://dx.doi.org/10.1016/0378-5173(94)90204-6
International search[Y]WO03028706  (SANWA KAGAKU KENKYUSHO CO [JP], et al);
 [Y]WO2007052592  (KOWA CO [JP], et al);
 [Y]JPH04346929  (TAKADA SEIYAKU KK);
 [Y]JP2003104887  (MARUKO PHARMACEUTICAL CO);
 [Y]JPS58109415  (TEISAN SEIYAKU KK);
 [Y]JPS4828621  (BAYER AG.);
 [Y]JPS5522645  (FUJISAWA PHARMACEUTICAL CO)
Examination   - THOMA K ET AL, "Photostabilization of drugs in dosage forms without protection from packaging materials", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, AMSTERDAM, NL, vol. 67, no. 2, doi:10.1016/0378-5173(91)90429-R, ISSN 0378-5173, (19910115), pages 169 - 175, (19910115), XP025557819

DOI:   http://dx.doi.org/10.1016/0378-5173(91)90429-R
by applicantJPS5522645
 JP2003104888
 JP2000007583
 JP2003028706
 JP2007091648
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.